Table 2.

Reasons for passing the clinical action performance measure for lipid management among diabetic patients age 50-75 (N=668,209)

	Hierarchical*		Total**
Reason	N	%	N	%
Index LDL < 100 mg/dL	448,738	67.2	448,738	67.2
On at least a moderate dose statin at the time of the index LDL1	50,032	7.5	317,736	47.6
Appropriate clinical action within 90 days following the index LDL (includes index LDL date)
On at least a moderate dose statin	29,571	4.4	70,627	10.6
Increase of statin dose (at a dose lower than moderate dose)	481	0.1	4,953	0.7
Start or change statin (at a dose lower than moderate dose)	5,727	0.9	86,355	12.9
Repeat LDL value < 100 mg/dL	775	0.1	19,099	2.9
No Index LDL, but received a fill for a moderate dose statin or higher during at end of measurement period2	29,674	4.4	29,674	4.4
MEETS THE CLINICAL ACTION MEASURE	564,998	84.6	564,998	84.6
DOES NOT MEET THE MEASURE	103,211	15.4	103,211	15.4

^*Patient can meet the measure based on only one reason, in the order listed

^**Patient can meet the measure based on all reasons for which they qualify

¹Patients were considered to already be on a statin if they had a medication fill within 100 days prior to the Index LDL;

²During the last 120 days of the measurement period.